日日夜夜导航|一区在线观看视频|国内精品久久久久久久久久鸭下载|国产福利一区二区|亚洲国产精品无码乱码三区电影|玖玖视频免费日本|日本欧美国产在线|日韩av免费在线|超碰97免费观看|中文字幕无码中文字幕人妻日日

Poly Pharm adheres to the advanced manufacturing positioning of "differentiation + vertical integration of API and finished product  + internationalization", strictly requiring drug quality comply with international GMP  standards. It has established a complete quality system, standardized quality management and control systems, procedures and standards. The company has accumulated rich technical reserves and experience in drug formulation technology research and formulation global registration. In recent years, the company has continuously increased its R&D investment in the combination of"generic and innovative" research, targeting at those products with high technical difficulty and differentiation, and it has established an innovative drug research institute, a biotechnology research institute, a generic drug research institute, and a API research institute, with over 550 R&D personnel, accounting for one-third of the company's total employees.